Dr. Tad Tillemans, M.D

NPI: 1346459765
Total Payments
$667,044
2024 Payments
$124,124
Companies
29
Transactions
1,009

Payment Breakdown by Category

Other$555,887 (83.3%)
Travel$48,568 (7.3%)
Consulting$45,693 (6.9%)
Food & Beverage$16,745 (2.5%)
Education$152.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $553,137 229 82.9%
Travel and Lodging $48,568 236 7.3%
Consulting Fee $45,693 16 6.9%
Food and Beverage $16,745 524 2.5%
Honoraria $2,750 1 0.4%
Education $152.00 3 0.0%

Top Paying Companies

Company Total Records Latest Year
Otsuka America Pharmaceutical, Inc. $538,357 660 $0 (2024)
Axsome Therapeutics, Inc. $44,366 47 $0 (2024)
Supernus Pharmaceuticals, Inc. $29,504 59 $0 (2024)
Takeda Pharmaceuticals U.S.A., Inc. $26,710 47 $0 (2024)
Takeda Pharmaceuticals America, Inc. $13,910 9 $0 (2017)
Shire North American Group Inc $6,010 18 $0 (2019)
IRONSHORE PHARMACEUTICALS INC. $4,758 17 $0 (2024)
ABBVIE INC. $774.60 39 $0 (2024)
Alkermes, Inc. $612.33 16 $0 (2024)
Janssen Pharmaceuticals, Inc $304.86 8 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2024 $124,124 181 Otsuka America Pharmaceutical, Inc. ($87,933)
2023 $116,492 175 Otsuka America Pharmaceutical, Inc. ($95,296)
2022 $92,818 137 Otsuka America Pharmaceutical, Inc. ($73,756)
2021 $35,044 76 Otsuka America Pharmaceutical, Inc. ($34,290)
2020 $57,708 94 Otsuka America Pharmaceutical, Inc. ($57,396)
2019 $98,114 145 Otsuka America Pharmaceutical, Inc. ($85,804)
2018 $71,756 103 Otsuka America Pharmaceutical, Inc. ($48,276)
2017 $70,989 98 Otsuka America Pharmaceutical, Inc. ($55,606)

All Payment Transactions

1,009 individual payment records from CMS Open Payments — Page 1 of 41

Date Company Product Nature Form Amount Type
12/19/2024 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $23.96 General
Category: Neuropsychiatry
12/18/2024 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,548.00 General
Category: PSYCHIATRY
12/14/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $27.59 General
Category: NEUROSCIENCE
12/12/2024 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $55.85 General
Category: PSYCHIATRY
12/11/2024 IRONSHORE PHARMACEUTICALS INC. JORNAY PM (Drug) Food and Beverage Cash or cash equivalent $22.14 General
Category: CENTRAL NERVOUS SYSTEM STIMULANT
12/10/2024 Axsome Therapeutics, Inc. Auvelity (Drug) Food and Beverage In-kind items and services $10.94 General
Category: Psychology/Psychiatric
12/03/2024 Axsome Therapeutics, Inc. Auvelity (Drug) Consulting Fee Cash or cash equivalent $2,250.00 General
Category: Psychology/Psychiatric
12/03/2024 Axsome Therapeutics, Inc. Auvelity (Drug) Food and Beverage In-kind items and services $103.67 General
Category: Psychology/Psychiatric
11/15/2024 Teva Pharmaceuticals USA, Inc. Austedo XR (Drug) Food and Beverage In-kind items and services $13.07 General
Category: Central Nervous System
11/15/2024 Teva Pharmaceuticals USA, Inc. Austedo XR (Drug) Food and Beverage In-kind items and services $2.36 General
Category: Central Nervous System
11/08/2024 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $17.77 General
Category: Neuropsychiatry
11/08/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $10.68 General
Category: NEUROSCIENCE
10/30/2024 Takeda Pharmaceuticals U.S.A., Inc. TRINTELLIX (Drug) Food and Beverage In-kind items and services $20.47 General
Category: NEUROSCIENCE
10/30/2024 Otsuka America Pharmaceutical, Inc. ABILIFY ASIMTUFII (Drug) Food and Beverage In-kind items and services $6.64 General
Category: PSYCHIATRY
10/29/2024 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $10.89 General
Category: PSYCHIATRY
10/25/2024 E.R. Squibb & Sons, L.L.C. Food and Beverage Cash or cash equivalent $15.77 General
10/23/2024 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $27.63 General
Category: PSYCHIATRY
10/16/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $11.13 General
Category: NEUROSCIENCE
10/16/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $9.20 General
Category: NEUROSCIENCE
10/11/2024 E.R. Squibb & Sons, L.L.C. COBENFY (Drug) Food and Beverage Cash or cash equivalent $16.44 General
Category: Psychiatry/Psychology
10/09/2024 Otsuka America Pharmaceutical, Inc. ABILIFY ASIMTUFII (Drug) Food and Beverage In-kind items and services $17.95 General
Category: PSYCHIATRY
10/08/2024 Teva Pharmaceuticals USA, Inc. Austedo XR (Drug) Food and Beverage In-kind items and services $5.27 General
Category: Central Nervous System
10/02/2024 Axsome Therapeutics, Inc. Auvelity (Drug) Food and Beverage In-kind items and services $62.50 General
Category: Psychology/Psychiatric
10/02/2024 IRONSHORE PHARMACEUTICALS INC. JORNAY PM (Drug) Food and Beverage Cash or cash equivalent $20.85 General
Category: CENTRAL NERVOUS SYSTEM STIMULANT
10/01/2024 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $10.34 General
Category: PSYCHIATRY

About Dr. Tad Tillemans, M.D

Dr. Tad Tillemans, M.D is a Psychiatry healthcare provider based in Little Rock, Arkansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/22/2007. The National Provider Identifier (NPI) number assigned to this provider is 1346459765.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Tad Tillemans, M.D has received a total of $667,044 in payments from pharmaceutical and medical device companies, with $124,124 received in 2024. These payments were reported across 1,009 transactions from 29 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($553,137).

Practice Information

  • Specialty Psychiatry
  • Location Little Rock, AR
  • Active Since 05/22/2007
  • Last Updated 04/04/2013
  • Taxonomy Code 2084P0800X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1346459765

Products in Payments

  • REXULTI (Drug) $537,949
  • Auvelity (Drug) $44,335
  • Trintellix (Drug) $40,023
  • QELBREE (Drug) $24,784
  • MYDAYIS (Drug) $5,963
  • Qelbree (Drug) $4,720
  • Jornay PM 20mg capsules (Bottle of 100) (Drug) $4,574
  • VRAYLAR (Drug) $793.18
  • ABILIFY MAINTENA (Drug) $380.66
  • TRINTELLIX (Drug) $360.43
  • LYBALVI (Drug) $335.31
  • SPRAVATO (Drug) $304.86
  • INGREZZA (Drug) $254.45
  • Entyvio (Biological) $196.20
  • JORNAY PM (Drug) $183.25
  • HETLIOZ (Drug) $179.18
  • ARISTADA (Drug) $158.72
  • Aristada 441 mg (Drug) $118.30
  • BRIXADI (Drug) $118.02
  • LATUDA (Drug) $97.03

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Psychiatry Doctors in Little Rock